Pfizer Japan
Japanese subsidiary of a research-driven biopharmaceutical company. Local activities include discovery and translational research collaborations; platform-based vaccine design and variant-update workflows; clinical trial design, execution and reporting; preparation of regulatory applications and post-approval lifecycle management in Japan; domestic GMP manufacturing, formulation development and scale-up at a long-operating manufacturing site in Nagoya; deployment of manufacturing performance and continuous-improvement programs across manufacturing sites; operation of digital information platforms for patients and healthcare professionals; administration of independent medical grants; and implementation of environmental, health & safety and sustainability programs. The organization also reports activities to promote diversity, equity & inclusion and employee well-being, and participates in cross-site global manufacturing collaboration.
Industries
Nr. of Employees
Very Large (1000+)
Patents
Large scale production process for capped and un-capped antibody cysteines and their use in therapeutic protein conjugation
US-12121588-B2
View DetailsCapped and uncapped antibody cysteines, and their use in antibody-drug conjugation
US-11980669-B2
View DetailsPurification of antibody drug conjugates using a sodium phosphate gradient
US-11661438-B2
View Details
Large scale production process for capped and un-capped antibody cysteines and their use in therapeutic protein conjugation
US-12121588-B2
View DetailsCapped and uncapped antibody cysteines, and their use in antibody-drug conjugation
US-11980669-B2
View DetailsPurification of antibody drug conjugates using a sodium phosphate gradient
US-11661438-B2
View DetailsProducts
Vaccines including variant-adapted formulations
Platform-based vaccines and variant-adapted formulations supplied in Japan for infectious disease prevention.
Prescription medicines (small molecules and biologics)
A portfolio of oral small molecules and biologic therapeutics for multiple therapeutic areas supplied in Japan.
Mobile applications for patient support
Mobile applications consolidating information and tools intended to support patients and caregivers for specific conditions.
Vaccines including variant-adapted formulations
Platform-based vaccines and variant-adapted formulations supplied in Japan for infectious disease prevention.
Prescription medicines (small molecules and biologics)
A portfolio of oral small molecules and biologic therapeutics for multiple therapeutic areas supplied in Japan.
Mobile applications for patient support
Mobile applications consolidating information and tools intended to support patients and caregivers for specific conditions.
Services
Grant funding and administrative support for investigator-initiated and community health research projects.
Centralized trial listings, investigator-site guidance and resources for participants and clinical sites.
Web portals and disease-specific educational sites providing disease and product information and support resources.
Local formulation development, quality control, final product inspection and commercial manufacturing services supporting supply within Japan.
Coordination of manufacturing and logistics across internal and external sites to maintain supply continuity and supplier compliance with quality standards.
Site-level deployment of integrated operations management frameworks and continuous-improvement activities to standardize processes and improve manufacturing performance.
Grant funding and administrative support for investigator-initiated and community health research projects.
Centralized trial listings, investigator-site guidance and resources for participants and clinical sites.
Web portals and disease-specific educational sites providing disease and product information and support resources.
Local formulation development, quality control, final product inspection and commercial manufacturing services supporting supply within Japan.
Coordination of manufacturing and logistics across internal and external sites to maintain supply continuity and supplier compliance with quality standards.
Site-level deployment of integrated operations management frameworks and continuous-improvement activities to standardize processes and improve manufacturing performance.
Expertise Areas
- Clinical trial management
- Vaccine platform development and variant-adapted workflows
- Formulation development and process scale-up
- GMP pharmaceutical manufacturing and facility operations
Key Technologies
- Good Manufacturing Practice (GMP) processes
- Formulation development and scale-up methods
- Large-scale fermentation and bioprocessing
- Quality management systems (QMS) and final product inspection
News & Updates
Announcement of additional pediatric dosing indication for an intravenous formulation (manufacturing/marketing authorization update).
Launch of a mobile application aggregating information and convenience features for cancer patients and caregivers.
Regulatory approval for variant-adapted COVID-19 vaccine formulations and associated presentations for pediatric and adult use.
Public communication regarding support and assistance for people affected by the Noto Peninsula earthquake.
Public-facing campaign materials and communications on appropriate antimicrobial use and AMR awareness.
Recognition in a corporate ranking for women in 2023.
Announcement of additional pediatric dosing indication for an intravenous formulation (manufacturing/marketing authorization update).
Launch of a mobile application aggregating information and convenience features for cancer patients and caregivers.
Regulatory approval for variant-adapted COVID-19 vaccine formulations and associated presentations for pediatric and adult use.
Public communication regarding support and assistance for people affected by the Noto Peninsula earthquake.
Public-facing campaign materials and communications on appropriate antimicrobial use and AMR awareness.
Recognition in a corporate ranking for women in 2023.